Showing results (21-30 of 54) with videos related to
Sort By:
Pageof 6
Acta Crystallographica. Section E, Structure Reports Online|June 22, 2012
N,N'-Bis(2,6-diisopropyl-phen-yl)-3,6-di-methyl-1,2,4,5-tetra-zine-1,4-dicarboxamideNa-Bo Sun, Guo-Wu Rao, Li-Ling ZhangActa Crystallographica. Section E, Structure Reports Online|May 18, 2011
2,5-Bis(9H-carbazol-9-yl)thio-pheneXu-Liang Jiang, Er-Fang Huang, Guo-Wu RaoActa Crystallographica. Section E, Structure Reports Online|June 22, 2012
1-{[3-(2-Chloro-3,3,3-trifluoro-prop-1-en-yl)-2,2-dimethyl-cyclo-propan-1-yl]carbon-yl}-3-(methyl-sulfon-yl)imidazolidin-2-oneNa-Bo Sun, Guo-Wu Rao, Jian-Bo ChuChemmedchem|April 28, 2012
Synthesis, structure analysis, and antitumor evaluation of 3,6-dimethyl-1,2,4,5-tetrazine-1,4-dicarboxamide derivativesGuo-Wu Rao, Yan-Mei Guo, Wei-Xiao HuFuture Medicinal Chemistry|July 17, 2024
Targeted small molecule therapy and inhibitors for lymphomaZhong-Hui Wang, Xiang Zheng, Guo-Wu Rao, et al.Current Medicinal Chemistry|May 20, 2024
Research Progress in the Use of Small Molecule Smac Mimetics in Combination Therapy of CancerJiang-Ting Zhao, Xiang Zheng, Guo-Wu Rao, et al.Current Medicinal Chemistry|November 8, 2023
A New Dawn for Targeted Cancer Therapy: Small Molecule Covalent Binding Inhibitor Targeting K-Ras (G12C)Na Li, Chen-Fu Liu, Wen Zhang, et al.Current Medicinal Chemistry|June 21, 2024
Targeting TYK2 for Fighting Diseases: Recent Advance of TYK2 InhibitorsSi-Shi Du, Yu-Qing Fang, Wen Zhang, et al.Current Medicinal Chemistry|October 6, 2022
Research Progress in Competitive Purine AntagonistsDan-Xia Ying, Peng-Cheng Zhao, Wen Zhang, et al.Current Medicinal Chemistry|August 31, 2022
Research Progress in Pharmacological Mechanisms, Structure-Activity Relationship and Synthesis of SartansYe-Fan Wang, Xin-Yue Ren, Wen Zhang, et al.Pageof 6